Sentences with phrase «from studying a patient»

«For a long time, we've thought of brain imaging studies as mainly a way to corroborate or confirm aspects of brain function and pathology that we had already identified from studying a patient's behavior,» said Aysenil Belger, PhD, professor of psychiatry and psychology at UNC and the study's senior author.

Grob and his co-investigators did offer snippets of letters and reactions from study patients.

The overriding finding from studying these patients is that the left brain doesn't seem to miss the right.

Develop study documents; garner consents from study patients, schedule study patient visits and clinical procedures.

Not exact matches

«From 2012 to 2015, the absolute number of patients treated with nitroprusside decreased by 53 %, and the number treated with isoproterenol decreased by 35 %,» wrote the study authors.

While the new mid-stage study results from DNDi were impressive (they showed cure rates of 96 % to 97 % even for the sickest patients and those with liver scarring), more late - stage trials will be necessary before the drug is available on a large scale in the developing world.

GOOGLE»S AI HELPS TO PREDICT CARDIOVASCULAR CONDITIONS BY ANALYZING EYE SCANS: Google and Verily — Google - parent Alphabet's life sciences unit — are exploring new ways that artificial intelligence (AI) can be used to identify patients» risk of suffering from a cardiovascular event, such as a heart attack or stroke, according to a newly published study by the two Alphabet subsidiaries.

In our symptom study, we obtained questionnaires from 7,847 patients about nasal, sinus and other health symptoms.

The study, published today in the journal Trauma Surgery & Acute Care Open, found most of the fictional patients (71 %) were transferred from emergency directly to the operating theatre.

Ahern has been overseeing a three - year study involving more than 200 patients who suffer from physical and psychiatric disorders.

For example, a small study of 38 patients with Alzheimer's from 2016 looked at the effects of Victoza.

BIIB098: MRI and relapse results from the phase 3 EVOLVE - MS - 1 study in patients with relapsing and remitting multiple sclerosis were presented at the 70th annual meeting of the American Academy of Neurology (AAN).

The study, by Yusuke Tsugawa and colleagues at the Harvard T. H. Chan School of Public Health, Harvard Medical School, and other institutions, examined the record of a large random sample of Medicare patients, 65 years or older, who were hospitalized from January 2011 to December 2014.

«Among both groups, patients taking Entresto had a 20 % or greater reduction in cardiovascular death or heart failure hospitalization compared to those taking enalapril,» Novartis said in a statement, citing conclusions based on analysis of data from the PARADIGM - HF study.

The study is patient - funded; participants, who range in age from late 30s through 80s, must pay $ 8,000 to take part, and live in or travel to Monterey for treatments and follow - up assessments.

In parallel, adjudication will be completed for all MACE which occurred during the study, including adjudication for certain events which, per protocol, can not be finally adjudicated until patients complete their final site visit and results are available from certain non-invasive diagnostic testing conducted during such site visits.

We are pleased that increasing numbers of physicians are prescribing Vascepa to help their patients and we are confident that the results from the REDUCE - IT study will lead to better informed decisions regarding patient care.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«Based on the results from these Phase 3 studies, the combination of bictegravir and FTC / TAF could represent an important advance in triple - therapy treatment for a broad range of HIV patients, and we look forward to submitting regulatory applications in the U.S. and EU this year.»

Join us for key insights from the CoMMpass Study, including results that patients and caregivers may find helpful for treatment decisions.

25,000 patients will be enrolled in the first study ever to combine data from genetics, cognitive tests and online surveys to explore how genetics is related to Major Depressive Disorder, Bipolar Depression and certain brain functions.

Interim results showed that a majority of the 22 patients in the two Phase 1/2 studies followed for two years or longer remained free from transfusions.

Presentations will highlight the short and long - term effects of Ingrezza on tardive dyskinesia symptoms by body region, long term safety and efficacy data from the KINECT 4 phase 3 open label study and also from RE-KINECT (real - world screening study of patients with possible TD).

Corbus» top - line data from a 22 - patient study of anabasum for the treatment of...

The study can only look for an effect from prayers offered as part of the research, they said.They also said they had no explanation for the higher complication rate in patients who knew they were being prayed for, in comparison to patients who only knew it was possible prayers were being said for them.»

As Gawande notes, a study conducted by Aetna Insurance permitting «concurrent care» — having access to both hospice and life - extending treatments — saw hospice participation rise from 26 to 70 percent of eligible patients.

From being studied to death, the Liturgy soon came to take on the contours of T. S. Eliot's famous «patient etherized on a table,» and appalled observers (and worshipers) had to witness after the Second Vatican Council the destruction of Catholic piety in the name of «renewal.»

When he attempted to create a general psychology of personality, based on his findings from studying neurotic patients, he did not see that health is much more than the absence of gross pathology.

cross-cultural studies which led him to assume inaccurately that he could extrapolate from the characteristics of mid-Victorian Viennese patients in describing a universal psychology.

A 2001 double - blind study at the Mayo Clinic randomized 799 discharged coronary surgery patients into a control group and an intercessory prayer group, which received prayers at least once a week from 5 intercessors per patient.

It is not completely determined what causes acid reflux, however studies have confirmed that most acid reflux patients had a hiatal hernia or are pregnant, suffer from obesity or are smoking.

â $ cents Results from the studies reviewed suggest that some patients exhibit symptoms at much lower doses of gluten than others.

A study conducted at the University of Oxford suggests that Alzheimer's and dementia patients have experienced short - term benefits resulting from consuming coconut oil, even though the results may be temporary.

Dr. Kellermayer is studying the effects of so - called «fecal transplants,» which involve giving participants in the study stool specimens from healthy adult individuals to change the microbes in the patient's gut.

In a new study commissioned by The March of Dimes Foundation and published in Fertility and Sterility, researchers from The Hastings Center and Yale Fertility Center examined the practical circumstances of infertility treatment in the US that influence patients and their doctors to make treatment choices that too frequently result in multiple births.

«At first, the patient is usually very frightened of the voice and will curl up in the chair and look away from the avatar,» explained professor Tom Craig, one of the study's authors.

Citing a 2010 study finding that patients who had at least two 2 rehabilitation visits for persistent dizziness after a concussion showed improvement in their DHI scores (2), the study said that on - field identification of dizziness could lead to earlier implementation of vestibular rehabiliation and other modalities to treat dizziness, which may expedite recovery from concussion.

In response to reports that women may be using this unapproved drug, to increase milk production (lactation), the WHO and FDA are warning breastfeeding women of safety concerns as «there have been several published reports and case studies of cardiac arrhythmias, cardiac arrest and sudden death in patients receiving an intravenous form of domperidone that has been withdrawn from the market in a number of countries.»

Additional information requested from the study group included position of breast scar, implant volume, and whether loss of nipple sensation had occurred after the surgery (as judged by the patient).

One study reviewed of 137 factors affecting women's satisfaction with childbirth, and 4 stood out: personal expectations, the amount of support from caregivers, the quality of the caregiver - patient relationship and involvement in decision making.

Previous research shows that giving an EPA - DHA supplement to patients with cardiovascular disease reduces their chance of dying from the disease by as much as 20 percent, authors note in the study, but supplementing with margarine didn't seem to cut it.

There is an irony that the report from the «Centre for policy studies» failed to mention that the NHS is the only public body, that we are aware of, that has it's own full time litigation authority costing some # 7 million per year set up to deal with the complaints from patients regarding treatment they have received from a healthcare system that is supposed to protect them.

As mentioned already the «Centre for policy studies» has said that the NHSLA has liabilities of some # 16.8 billion, reducing this figure would make huge inroads to the efficiency saving the NHS has to make without compromising patient safety and staff numbers It would be wise for those within the NHS and from the «Centre for policy studies» to look to their own as for the reason why patients look to the law for recompense, before we say that the compensation culture is «ingrained in the national psyche as a warped form of normal behaviour».

It does not include medical information, apart from for cancer patients or those participating in studies.

As well as the water club study, the team looked at patients recovering from stroke, and the value of group nostalgia among people with dementia, as well as several other studies.

The push for the database stems from a study published earlier this month in the Annals of Internal Medicine which found 91 % of the 2,848 patients who had previously overdosed were later prescribed opioids by their doctors.

According to a report from the National Cancer Institute, a study of 30 randomized studies found that THC (the active ingredient in marijuana) extracts outperformed traditional anti-nausea drugs and helped patients gain weight.

Since the neuronal death can be recapitulated in directly reprogrammed patient neurons, Yoo said the new technique offers a way to study the details of how potential therapies — including drugs that are currently being tested in clinical trials — could rescue medium spiny neurons from death.

Researchers studied records for all patients in Maryland's Trauma Registry recorded as directly admitted to the hospital from the scene or transferred to trauma centers between July 1, 2000 and June 30, 2011.

Huntington's disease and other inherited brain conditions are challenging to study because it is difficult to obtain samples of neurons from living patients.